Toxicity Profile of Brexucabtagene Autoleucel (brexu-cel; CD19-directed CAR T-cell therapy) in Adult Patients (pts) with Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from a Multicenter Real-World Outcomes Study Kopmar, N. E., Gooley, T., Roloff, G. W., Aldoss, I., Lin, C., Dekker, S. E., Gupta, V. K., Jeyakumar, N., O'connor, T., Dykes, K. C., Ahmed, M., Zambrano, H., Bradshaw, D., Mercadal, S., Schwartz, M., Tracy, S., Dholaria, B., Kubiak, M., Mukherjee, A., Majhail, N., Battiwalla, M., Mountjoy, L., Malik, S., Shaughnessy, P., Mathews, J., Logan, A. C., Ladha, A., Yaghmour, G., Advani, A. S., Stefan, M., Guzowski, C., Hoeg, R. T., Hilal, T., Moore, J., O'Dwyer, K. M., Tsai, S. B., Sasine, J., Solh, M. M., Lee, C. J., Kota, V. K., Koura, D., Veeraputhiran, M., Blunk, B., Leonard, J. T., Oliai, C. H., Bachanova, V., Stock, W., Galal, A., Pullarkat, V., Shah, B. D., Faramand, R., Muffly, L. S., Cassaday, R. D. AMER SOC HEMATOLOGY. 2023

View details for DOI 10.1182/blood-2023-185107

View details for Web of Science ID 001159306702035